The Effect of Ablation Depth on Dry Eye After LASIK Treatment of Myopia
NCT ID: NCT03228784
Last Updated: 2017-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2013-06-01
2014-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Angle Kappa and Corneal Back Elevations After Laser in Situ Keratomileusis in Myopic Astigmatism
NCT06166212
Evaluation of Visual Outcomes After Myopic LASIK
NCT00366743
Hyperopic LASIK With Crosslinking Versus Standard LASIK
NCT03224013
Comparison Between the SBK Microkeratome Versus Femtosecond Laser in Flap Creation During LASIK Surgery for Myopia
NCT05406973
Short Term Refractive and Ocular Parameter Changes After Topical Atropine
NCT03839888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LASIK
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal Pentacam maps
* Myopia with spherical equation less than 12 D
* Corneal thickness ≥ 500 Microns
* Calculated residual stromal bed ≥ 280 microns
* No signs or symptoms of dry eye.
Exclusion Criteria
* Auto-immune diseases
* History of dry eye or previous use of tear substitutes
* Previous ocular surgery
* Pregnant or lactating women.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hosny Ahmed Zein
Principle Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5780
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.